-
公开(公告)号:US20150224086A1
公开(公告)日:2015-08-13
申请号:US14422884
申请日:2013-08-05
Applicant: Hetero Research Foundation
Inventor: Bandi Parthasaradhi Reddy , Podili Khadgapathi , Goli Kamalakar Reddy
IPC: A61K31/4192 , A61K47/32
CPC classification number: A61K31/4192 , A61K9/2027 , A61K9/2054 , A61K47/32
Abstract: The present invention relates to pharmaceutical compositions comprising rufmamide premix and one or more pharmaceutically acceptable excipients and methods of preparing the same.
Abstract translation: 本发明涉及包含rufmamide预混物和一种或多种药学上可接受的赋形剂的药物组合物及其制备方法。
-
公开(公告)号:US20150182629A1
公开(公告)日:2015-07-02
申请号:US14412339
申请日:2013-06-27
Applicant: HETERO RESEARCH FOUNDATION
Inventor: Bandi Parthasaradhi Reddy , Podili Khadgapathi , Borra Syamprasad
CPC classification number: A61K47/36 , A61K9/2013 , A61K9/2054 , A61K9/2059 , A61K31/195 , A61K31/222 , A61K47/12 , A61K47/14 , A61K47/38
Abstract: Stable pharmaceutical compositions of fesoterodine or its pharmaceutically acceptable salt thereof and process for preparing the same. In a first embodiment, a stable pharmaceutical composition is provided comprising fesoterodine fumarate, glyceryl behenate and a stabilizer. The stable pharmaceutical tablet composition may further comprise i) fesoterodine fumarate in an 5 amount of 1% to 5% by weight, ii) glyceryl behenate in an amount of 1% to 8% by weight, iii) pregelatinized starch in an amount of 30% to 50% by weight and iv) a stabilizer in an amount of 0.1% to 10% by weight based on total weight of the composition.
Abstract translation: 非索罗定或其药学上可接受的盐的稳定的药物组合物及其制备方法。 在第一个实施方案中,提供了稳定的药物组合物,其包含富马酸菲索特罗,山特酸甘油酯和稳定剂。 稳定的药物片剂组合物可以进一步包含i)5重量%的1重量%至5重量%的富马酸非索罗定,ii)1重量%至8重量%的山嵛酸甘油酯,iii)预胶化淀粉的量为30 %至50重量%,和iv)基于组合物总重量的0.1重量%至10重量%的稳定剂。
-
公开(公告)号:US09345712B2
公开(公告)日:2016-05-24
申请号:US14436284
申请日:2013-10-23
Applicant: HETERO RESEARCH FOUNDATION
Inventor: Bandi Parthasaradhi Reddy , Podili Khadgapathi , Goli Kamalakar Reddy
CPC classification number: A61K31/55 , A61K9/10 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2072 , A61K9/2095
Abstract: The present invention relates to solid dispersion compositions of tolvaptan and process for the preparation of oral dosage forms.
Abstract translation: 本发明涉及托伐普坦的固体分散体组合物和制备口服剂型的方法。
-
公开(公告)号:US20150246053A1
公开(公告)日:2015-09-03
申请号:US14436284
申请日:2013-10-23
Applicant: HETERO RESEARCH FOUNDATION
Inventor: Bandi Parthasaradhi Reddy , Podili Khadgapathi , Goli Kamalakar Reddy
CPC classification number: A61K31/55 , A61K9/10 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2072 , A61K9/2095
Abstract: The present invention relates to solid dispersion compositions of tolvaptan and process for the preparation of oral dosage forms.
Abstract translation: 本发明涉及托伐普坦的固体分散体组合物和制备口服剂型的方法。
-
公开(公告)号:US09770437B2
公开(公告)日:2017-09-26
申请号:US14915714
申请日:2014-09-01
Applicant: HETERO RESEARCH FOUNDATION
Inventor: Bandi Parthasaradhi Reddy , Podili Khadgapathi , Nelluri Ramarao
IPC: A61K9/20 , A61K9/26 , A61K31/415 , A61K31/4152
CPC classification number: A61K31/4152 , A61K9/2054 , A61K9/2059 , A61K9/2077
Abstract: The present invention relates to compositions of eltrombopag olamine. The present invention also relates to process for preparing compositions comprising eltrombopag olamine.
-
公开(公告)号:US20150140101A1
公开(公告)日:2015-05-21
申请号:US14412110
申请日:2013-06-27
Applicant: HETERO RESEARCH FOUNDATION
Inventor: Bandi Parthasaradhi Reddy , Podili Khadgapathi , Goli Kamalakar Reddy
CPC classification number: A61K31/404 , A61K9/14 , A61K9/1623 , A61K9/1652 , A61K9/2013 , A61K9/2018 , A61K9/2059 , A61K9/4833 , A61K9/4858 , A61K9/4866 , A61K31/4045 , A61K47/12 , A61K47/26 , A61K47/36 , A61K47/38
Abstract: The present disclosure relates to solid oral compositions of silodosin or its pharmaceutically acceptable salt thereof. More particularly capsule compositions of silodosin with one or more pharmaceutically acceptable excipients and process for their preparation.
Abstract translation: 本公开涉及西洛多辛或其药学上可接受的盐的固体口服组合物。 更具体地,具有一种或多种药学上可接受的赋形剂的西洛多辛胶囊组合物及其制备方法。
-
公开(公告)号:US20150045400A1
公开(公告)日:2015-02-12
申请号:US14382075
申请日:2013-02-18
Applicant: Bandi PARTHASARADHI REDDY , Podili KHADGAPATHI , Goli KAMALAKAR REDDY , HETERO RESEARCH FOUNDATION
Inventor: Bandi Parthasaradhi , Podili Khadgapathi , Goli Kamalakar Reddy
IPC: A61K31/427 , A61K47/32 , A61K45/06
CPC classification number: A61K31/427 , A61K9/146 , A61K9/2027 , A61K31/426 , A61K45/06 , A61K47/32
Abstract: The present invention relates to pharmaceutical compositions comprising ritonavir premix, a water soluble polymer and a surfactant and process for preparing the same. More particularly, the present invention relates to hot-melt extrusion process for preparing solid oral compositions of ritonavir premix.
Abstract translation: 本发明涉及包含利托那韦预混物,水溶性聚合物和表面活性剂的药物组合物及其制备方法。 更具体地,本发明涉及用于制备利托那韦预混物的固体口服组合物的热熔挤出方法。
-
-
-
-
-
-